BeyondSpring (BYSI) Other Working Capital Changes (2017 - 2026)
BeyondSpring's (BYSI) quarterly Other Working Capital Changes came in at $145000.0 in Q2 2026, up 185.8% year-over-year from $50735.0 in Q2 2025, and down 42.91% quarter-over-quarter from $254000.0 in Q1 2026.
Powered by 
Analysis
BeyondSpring (BYSI) Other Working Capital Changes (2017 - 2026) Analysis & Trends
BeyondSpring has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $145000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 185.8% year-over-year to $145000.0; the TTM figure through Jun 2026 stood at $37000.0 (up 105.53% YoY), while the FY2025 annual figure was -$709000.0, down 12.36% from the prior year.
- Other Working Capital Changes came in at $145000.0 for Q2 2026 at BeyondSpring, down from $254000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $500000.0 in Q1 2024 to a low of -$501000.0 in Q3 2024.
- Average Other Working Capital Changes over 3 years is -$400200.0, with a median of -$500000.0 recorded in 2024.
- Year-over-year, Other Working Capital Changes fell 17.11% in 2025 and soared 242.7% in 2026.
- Over 3 years, Other Working Capital Changes stood at -$162000.0 in 2024, then dropped by 16.67% to -$189000.0 in 2025, then surged by 176.72% to $145000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $145000.0 in Q2 2026, $254000.0 in Q1 2026, and -$189000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 145,000.00 |
| Jun 30, 2026 | 145,000.00 |
| Mar 31, 2026 | 254,000.00 |
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -173,000.00 |
| Sep 30, 2025 | -173,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Dec 31, 2024 | -162,000.00 |
| Dec 31, 2024 | -162,000.00 |
| Sep 30, 2024 | -160,000.00 |
| Sep 30, 2024 | -160,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Jun 30, 2024 | -157,000.00 |
| Mar 31, 2024 | -152,000.00 |
| Mar 31, 2024 | -152,000.00 |